BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Trudell develops Aerobika to help treat symptoms of COPD patients

July 3, 2014
By Omar Ford

Infraredx enrolls 1st patient in PROSPECT II, seeks more data

July 2, 2014
By Omar Ford

Stryker in plan to acquire assets of Small Bone Innovations for $375M

July 1, 2014
By Omar Ford
Small Bone Innovations (Morrisville, Pennsylvania) joins the list of smaller, yet well established med-tech firms to have assets acquired by a larger player in the space. This time out, Stryker (Kalamazoo, Michigan) is the acquiring company, picking up SBI's assets in an all-cash transaction for up to $375 million.
Read More

ReWalk Robotics secures FDA clearance for exoskeleton for paraplegic patients

June 30, 2014
By Omar Ford
In 1997, Amit Goffer, an Israeli inventor, was severely paralyzed as a result of an ATV accident. Not content with his condition or the level of innovation available for paralyzed patients, Goffer, who is now a quadriplegic, began work on mobility devices. His work paid off as he eventually developed an exoskeleton to help paraplegic patients walk.
Read More

PwC projects healthcare spending to rise in 2015 due to stronger economy

June 27, 2014
By Omar Ford
After a five-year contraction in employer healthcare spending growth, medical inflation in the U.S. is projected to rise to 6.8% in 2015, according to PricewaterhouseCoopers (PwC; New York) Health Research Institute (HRI). In its annual report, Medical Cost Trend: Behind the Numbers, HRI projects that the stronger economy is now reaching the health sector, releasing a pent-up demand for care and services.
Read More

Karl Storz releases solutions that improve visualization of anatomy

June 25, 2014
By Omar Ford

MRI Interventions, Monteris in brain tumor laser ablation accord

June 24, 2014
By Omar Ford

NewCo on the Go: Researchers make lightweight imaging tools that could aid in tumor detection

June 23, 2014
By Omar Ford
Researchers have developed a new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real time in the operating room.
Read More

Medtronic's AdaptivCRT therapy could lead to reduced healthcare costs

June 19, 2014
By Omar Ford
New data from Medtronic's (Minneapolis) Adaptive CRT trial show a 61% lower risk of atrial fibrillation (AF)-related problems in patients who receive a cardiac resynchronization therapy-defibrillator (CRT-D) with the Medtronic-exclusive AdaptivCRT algorithm compared to conventional biventricular pacing therapy. The data also indicate a 55% relative reduction in healthcare utilizations (HCUs, including hospitalizations, emergency department or clinic visits) when patients have devices with AdaptivCRT.
Read More

AdvaMed study disputes med-tech as factor for increased healthcare costs

June 18, 2014
By Omar Ford
Previous 1 2 … 82 83 84 85 86 87 88 89 90 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing